Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical, Genetic, and Cellular Consequences of Mutations in the NA,K-ATPase ATP1A3

NCT00682513 is registered in ClinicalTrials.gov with State University of New York at Buffalo as lead sponsor.

NCT NCT00682513
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00682513 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical, Genetic, and Cellular Consequences of Mutations in the NA,K-ATPase ATP1A3
Lead sponsor
State University of New York at Buffalo
Phase
Observational
Overall status
Active, not recruiting
Start date
April 30, 2008
Completion date
July 31, 2027
Enrollment
198 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

dystonia, parkinsonism